Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Pinealoma 1Neuroma, Acoustic 1Neoplasms, Germ Cell and Embryonal 1Mouth Neoplasms 1Meningioma 1Medulloblastoma 1Glioma 1Glioblastoma 1Ependymoma 1Craniopharyngioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

tocilizumab 2Radiotherapy 2Proton Therapy 2trifluridine tipiracil drug combination 1tozuleristide 1tovorafenib 1binimetinib 1anlotinib 1Tumor Burden 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Radiotherapy, Image-Guided 1Qsymia 1Phentermine 1Oxaliplatin 1Nivolumab 1Methionine 1Leucovorin 1Fluorouracil 1Exenatide 1Contrast Media 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Craniopharyngioma × tozuleristide × 1 year × Clear all
NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Cedars-Sinai Medical Center

Phase 2 Completed
50 enrolled
CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡